SciELO - Scientific Electronic Library Online

 
vol.29 número1Validación del índice QOL-RA (Quality of Life-Rheumatoid Arthritis) en una cohorte argentina de pacientes con artritis reumatoidea índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista argentina de reumatología

versão impressa ISSN 0327-4411versão On-line ISSN 2362-3675

Resumo

SCOLNIK, Marina; SCAGLIONI, Valeria; MAGRI, Sebastián Juan  e  BABINI, Alejandra Magdalena. Management of giant cell arteritis in Argentine: Vasculitis Study Group Survey. Rev. argent. reumatolg. [online]. 2018, vol.29, n.1, pp.11-14. ISSN 0327-4411.

Introduction: Up to now, Giant Cell Arteritis (GCA) diagnosis has relied on clinical features and temporal artery biopsy. In the last few years, new diagnostic tools are available and recently new treatments have appeared. Objectives: To describe a real world scenario of current GCA management in Argentine. Methods: A short online survey was developed by members of the Argentinian Society Vasculitis Study Group and emailed to all society adherents. Results: 188 answers were obtained. Only 13.4% of treating physicians can obtain a temporal biopsy in the majority of their GCA-suspected patients, while 45% of doctors can perform a temporal Doppler ultrasound. Corticosteroids dose and treatment duration is variable. Use of other treatments besides steroids is rare. Conclusion: GCA treatment in Argentina is based on long term corticosteroids, with scarce use of other immunosuppressants. Temporal Doppler ultrasound seems to have greater availability than temporal biopsy as a diagnostic tool.

Palavras-chave : arteritis; vasculitis; treatment.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons